Immunoreceptors and Immunotherapy

Since 1987, this conference has fostered a highly interactive community of researchers focused on solving important problems in immunoreceptor and immunotherapy biology. It brings together scientists from academia, government, and industry to discuss cutting-edge developments in this exciting area of research. 

The conference has a history of driving major advances in immunotherapies by bringing together leading scientists, clinicians, and industry experts to share the latest discoveries and technological advances. 

This year’s program will continue that tradition of innovation by examining the structural and functional dynamics of immunoreceptors, their mechanisms of activation and regulation, and translational research driving new immunotherapeutic strategies. As key molecules that regulate immune responses, research into immunoreceptors has yielded precise and effective therapies, including checkpoint inhibitors, CAR-T cell therapies, and novel monoclonal antibodies.

Attendees will learn about:

· Recent discoveries in immunoreceptor and immunotherapy biology.

· State-of-the-art technologies in structural biology, imaging, and therapeutic approaches.

· How immunoreceptors influence disease progression and treatment outcomes.

Program Topics

· Structural and spatial biology of immunoreceptors

· T cells: TCR and co-receptors

· B cells: BCR and co-receptors

· Myeloid cells: innate sensors

· Sensing antibodies: Fc Receptors

· Immunoreceptors in disease and immunotherapy

Workshops

During lunch breaks, Meet the Experts will feature small-group discussions with leading scientists and session chairs. These informal gatherings provide a unique opportunity for attendees to engage directly with experts on topics ranging from research strategies to career advice.

The Career Development Workshop will provide early-career researchers and faculty guidance on diverse career paths in academia and industry. A panel of professionals from various sectors, including academia, biotech, and industry, will share their experiences and answer questions in an open Q&A format.